ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,659Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 1456

$1.27M Total Retail Price of All Prescriptions

Rank: 61 out of 1456

691 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 19,612 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 940 732 1 4
HYDROCODONE-ACETAMINOPHEN 834 508 S3 2 6
SIMVASTATIN 821 614 3 2
FUROSEMIDE 782 623 4 7
LISINOPRIL 781 598 5 3
AMLODIPINE BESYLATE 769 588 6 1
HYDROCHLOROTHIAZIDE 592 462 7 10
TRAMADOL HCL 589 389 8 17
GABAPENTIN 573 389 9 13
OMEPRAZOLE 501 377 10 5
POTASSIUM CHLORIDE 454 344 11 15
ZOLPIDEM TARTRATE 454 311 11 14
METFORMIN HCL 430 289 13 8
WARFARIN SODIUM 421 351 14 21
DONEPEZIL HCL 337 322 15 29
METOPROLOL TARTRATE 320 257 16 12
CARVEDILOL 305 257 17 20
CITALOPRAM HBR 293 184 18 22
LIOTHYRONINE SODIUM 275 192 19 247
RANITIDINE HCL 272 169 20 27
FAMOTIDINE 265 210 21 45
DICLOFENAC SODIUM 260 164 22 95
CAPTOPRIL 252 173 23 310
NEXIUM 250 186 24 23
MELOXICAM 249 230 25 30
NAMENDA 241 233 26 38
SERTRALINE HCL 226 171 27 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 219 170 28 24
FLUCONAZOLE 195 95 29 148
LACTULOSE 192 186 30 192
RISPERIDONE 181 140 31 72
CLONIDINE HCL 167 117 32 39
PRENATAL PLUS 165 142 33 386
GLIPIZIDE 165 114 33 53
DIGOXIN 157 135 35 62
NUEDEXTA 155 122 36 289
ATENOLOL 148 121 37 18
CIPROFLOXACIN HCL 146 114 38 58
CLOPIDOGREL 143 124 39 32
LOSARTAN POTASSIUM 143 114 39 16
ATORVASTATIN CALCIUM 142 122 41 11
INSULIN SYRINGE 141 103 42 64
MIRTAZAPINE 137 124 43 65
TRIAMCINOLONE ACETONIDE 128 115 44 158
DIOVAN 128 117 44 35
ALLOPURINOL 124 105 46 31
AMOX TR-POTASSIUM CLAVULANATE 122 73 47 118
ESCITALOPRAM OXALATE 121 89 48 74
HYDRALAZINE HCL 120 94 49 48
GLIMEPIRIDE 117 84 50 33
BENAZEPRIL HCL 117 80 50 57
METOPROLOL SUCCINATE 117 116 50 19
LANTUS 116 99 53 50
TRAZODONE HCL 114 61 54 47
LYRICA 113 86 55 91
PLAVIX 112 100 56 46
GLIPIZIDE ER 110 96 57 86
PRAVASTATIN SODIUM 108 58 58 9
EXELON 108 108 58 105
ARMOUR THYROID 106 65 R 60 358
PREMARIN 105 79 R 61 99
PAROXETINE HCL 103 74 62 67
TERAZOSIN HCL 103 89 62 142
ALBUTEROL SULFATE 102 56 64 136
PANTOPRAZOLE SODIUM 101 96 65 43
FLUOXETINE HCL 101 63 65 55
ADVAIR DISKUS 99 76 67 63
FLUTICASONE PROPIONATE 97 76 68 28
AMITRIPTYLINE HCL 95 84 R 69 70
PRAMIPEXOLE DIHYDROCHLORIDE 95 80 69 203
FENOFIBRATE 94 64 71 56
PREDNISONE 86 46 72 42
OXYBUTYNIN CHLORIDE 84 58 73 156
LEVOTHROID 83 54 74 186
CEPHALEXIN 83 64 74 123
VERAPAMIL ER 81 62 76 82
AZITHROMYCIN 81 61 76 44
GLIPIZIDE XL 81 60 76 134
ROPINIROLE HCL 80 57 79 90
TRICOR 80 62 79 92
ENDOCET 80 22 S2 79 146
NOVOLOG MIX 70-30 78 50 82 204
LEVEMIR 77 35 83 161
SPIRONOLACTONE 76 42 84 73
CYCLOBENZAPRINE HCL 76 35 R 84 66
MECLIZINE HCL 75 69 86 101
KLOR-CON M20 72 42 87 51
CYMBALTA 71 42 88 52
TAMSULOSIN HCL 70 62 89 34
LEXAPRO 70 55 89 206
NABUMETONE 68 48 91 212
CRESTOR 67 42 92 26
CALCITONIN-SALMON 67 60 92 306
SPIRIVA 67 56 92 75
ESTRADIOL 67 37 R 92 153
DILTIAZEM HCL 66 55 96 223
CARISOPRODOL 66 0 R 96 80
QUETIAPINE FUMARATE 65 53 98 78
PROMETHAZINE HCL 65 45 R 98 77
ENALAPRIL MALEATE 65 53 98 87
CARBIDOPA-LEVODOPA 64 64 101 141
QUINAPRIL HCL 63 41 102 155
NITROFURANTOIN MONO-MACRO 62 52 103 182
LOVASTATIN 62 53 103 40
TRIAMTERENE-HCTZ 62 48 103 49
PROPRANOLOL HCL 61 26 106 143
SUCRALFATE 61 46 106 171
RAMIPRIL 60 40 108 98
DIOVAN HCT 60 43 108 59
HYDROXYZINE HCL 60 30 R 108 164
PEN NEEDLE 59 46 111 131
INDOMETHACIN 59 39 R 111 311
LABETALOL HCL 56 36 113 180
LAMOTRIGINE 56 15 113 258
NOVOLIN R 54 47 115 133
CLARITHROMYCIN 54 32 115 412
JANUVIA 54 43 115 68
BUMETANIDE 54 42 115 191
DOXYCYCLINE HYCLATE 53 27 119 129
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 30 120 107
OLANZAPINE 51 36 121 183
COLCRYS 51 47 121 122
FENTANYL 51 51 S2 121 114
KETOCONAZOLE 50 41 124 241
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.